Janney Montgomery Scott
MTNB icon

Janney Montgomery Scott’s Matinas BioPharma MTNB Stock Holding History

Janney Montgomery Scott’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-210
Closed -$14K – 2325
2020
Q4 		$14K Sell
210
-170
-45% -$7.87K ﹤0.01% 2216
2020
Q3 		$15K Hold
380
– – ﹤0.01% 2055
2020
Q2 		$15K Sell
380
-80
-17% -$3.07K ﹤0.01% 1979
2020
Q1 		$14K Buy
460
+160
+53% +$9.66K ﹤0.01% 1860
2019
Q4 		$34K Buy
+300
New +$17.4K ﹤0.01% 2043

Other funds holding MTNB

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Janney Montgomery Scott's MTNB Position: Q1 2021 in Review

Janney Montgomery Scott sold out of Matinas BioPharma (MTNB) in Q1 2021, closing a stake of 210 shares — an estimated $14K sold.

Janney Montgomery Scott first reported a position in MTNB in Q4 2019 and held it in 5 quarters. The position peaked at $34K in Q4 2019. 80 funds tracked by Wall St. Rank hold MTNB as of Q1 2021.

  • Janney Montgomery Scott reported no remaining Matinas BioPharma position as of Q1 2021 after selling out during the quarter.
  • Janney Montgomery Scott sold 210 Matinas BioPharma shares in Q1 2021, an estimated $14K.
  • Janney Montgomery Scott first reported a position in Matinas BioPharma in Q4 2019 and held it in 5 quarters.
  • Janney Montgomery Scott's Matinas BioPharma position peaked at $34K in Q4 2019.
  • 80 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2021.

Based on Janney Montgomery Scott's 13F filing for Q1 2021, filed 27 Apr 2021.